Noah Berkowitz insider trades

Open-market stock purchases and sales by Noah Berkowitz, Chief Medical Officer at Iovance Biotherapeutics, Inc, from SEC Form 4 filings since Mar 18, 2024.

Recent trades

DateStockTradeValue
Sep 30, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
Sep 30, 2026IOVA Iovance Biotherapeutics, IncBought (not open market)—
May 11, 2026ARVN Arvinas, IncSold$110K
Mar 18, 2026ARVN Arvinas, IncSold$71.4K
Feb 26, 2026ARVN Arvinas, IncBought (not open market)—
Feb 26, 2026ARVN Arvinas, IncBought (not open market)—
Feb 13, 2026ARVN Arvinas, IncSold$67.6K

Companies traded

  • IOVA Iovance Biotherapeutics, Inc: other filings, last Sep 30, 2026
  • ARVN Arvinas, Inc: 4 sales, last May 11, 2026

Get free alerts when Noah Berkowitz files a new trade →